Assessment of effectiveness and impact of universal prophylaxis with nirsevimab for prevention of hospitalizations due to respiratory syncytial virus in infants. The NIRSE-GAL study protocol
Nirsevimab has been recently licensed for universal RSV prophylaxis in infants. NIRSE-GAL is a three-year population-based study initiated in Galicia in September 2023.
One Health: a joint framework for action published by five EU agencies
ECDC, ECHA, EEA, EFSA and EMA publishes a joint framework for action to strengthen cooperation to support the implementation of the One Health agenda in the European Union.
|
9th Influenza Conference 2023
Scientific highlights of the 9th ESWI Influenza Conference
With promising developments in the field of respiratory viral infections, the conference sessions covered hot topics on seasonal, pandemic, and zoonotic influenza viruses, as well as other respiratory viruses such as RSV and SARS-CoV-2.
From birds, to cattle, to … us? Could bird flu be the next pandemic? podcast
As bird flu is confirmed in 33 cattle herds across eight US states, science editor of the Guardian Ian Sample talks to virologist Dr Ed Hutchinson of Glasgow University and ESWI Board member about why this development has taken scientists by surprise
News
Policy & Recommendations
WHO Europe launches the first Pan-European Network for Disease Control
Hosted by UKHSA and initially chaired by Dame Jenny Harries, the new Network will strengthen disease surveillance and outbreak response across the European Region
Socio-Economic Value of Adult Immunisation Programmes report
Adult vaccines can return up to 19 times their initial investment to society, when their significant benefits beyond the healthcare system are monetised. This report has been conducted by the Office of Health Economics.
Healing the health workforce: A call to action for EU institutions
Civil organisations, patients’ advocacy groups and healthcare professional associations urge European policymakers to address the health workforce crisis by implementing solutions that prioritise the well-being of health workers.
Time for Top Leaders to Join Pandemic Negotiations
Two final – and likely sleepless – weeks of negotiation on the pandemic agreement began on Monday 18 March, and negotiators have been urged to bring in their principals to ensure speed up decision-making.
European Patients’ Rights Day: Addressing skills shortage, medical desertification and job strain
Ahead of European Patients’ Rights Day, Mariano Votta, Director of Active Citizenship Network, discusses how the event will tackle the skills shortage, medical desertification and job strain in the healthcare sector.
European Immunization Week 2024: Prevent. Protect. Immunise
WHO European Region celebrates the European Immunization Week in April to promote awareness of the importance of immunisation in preventing diseases and protecting life.
COVID-19 Shows Why the World Needs a Pandemic Agreement
Dr. Tedros Adhanom Ghebreyesus on how we must prepare now to counter the threat of a future pandemic.
|
ESWI Respiratory Virus Summit 2024
ESWI Summit 2024: Conclusions
Conclusions by Peter Openshaw, Co-Chair of the the ESWI Respiratory Virus Summit 2024